Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury
Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of an infusion of Ronopterin (VAS203) on clinical outcome
in patients with moderate and severe traumatic brain injury. Half of the participants will
receive Ronopterin (VAS203), while the other half will receive placebo.